Angle Share Discussion Threads

[jelenko] 26/1/2024 07:24

Breakthrough approval is very Limited in what can be done with it. Also Parsortix is more about dealing with patients already diagnosed, it is not aimed at the screening market yet. The main objective of Parsortix is to harvest live cells for detailed analysis to guide medication.

[davemac3] 26/1/2024 04:24

Maybe not, is this competition?

[davemac3] 26/1/2024 04:14

Is this Parsortix?

[atmysignal] 25/1/2024 23:46

Bones, are you calling this a sell at 17p?

[waterloo01] 25/1/2024 23:10

Soletrader. You can tick off false positives. Not possible with live cell capture

[bones699] 25/1/2024 22:33

This is sinking so fast market cap £42m for a heavily loss making business running out of cash which has a product that's not selling!...Recipe for a Diaster I would say!

[bones699] 25/1/2024 22:31

How many Parsortix machines have been sold to date?

[htrocka2] 25/1/2024 22:10

Anyone in the medical world buying this product will undoubtedly do their home work. If it's promoted beyond its remit the competitors will be the first to complain to the FDA and no doubt screaming for it to be withdrawn.

[bones699] 25/1/2024 21:13

confusing trying to market a product that only has FDA approval for breast cancer testing while claiming it can be used for testing all other cancers...Think this could land AGL into serious hot water as the FDA doesn't look kindly on manufacturers disclaimers!

[vatnabrekk] 25/1/2024 20:16

I'm not sure it's true to say that it's only got one use bones?

[bones699] 25/1/2024 19:44

Doesn't look good here watching paint dry...How can you market a product that only has one use when the lab customer wants a multi cancer testing machine?

Hence no material commercial deals signed!

[dave4545] 25/1/2024 16:15

No problem

Happy for AGL talk and long term talk on here. I like to talk about the mm games when online.

Little shake to 17.5p offer but only 50k max online 17.425p so hoping their one sell they all sell will bail out mm's yet again, cannot see it happening this time I hope

[robow] 25/1/2024 15:52

Thanks Dave for setting up this thread

[broom23] 25/1/2024 15:45

Waterloo, upon reading Signal's message on downticks I was curious and had a look. I inadvertently added to the number of downticks when trying to see whom had posted the first one. Please accept my apologies - I cannot seem to rectify it.

[bones698] 25/1/2024 15:44

That will be tgtd aka bones699 aka PPE then lol

[atmysignal] 25/1/2024 15:33

The poster going around downticking good informative posts probably is the type who kicks a cat in its stomach when waking along the pavement, when no one is looking.

[waterloo01] 25/1/2024 15:06

Toffeeman, no not directly but where the FDA go, others usually follow. Almost certainly a non issue as it's unlikely to be passed. It does however highlight this whole area which has limited regulation. Agree either way, Parsortix is well placed.

Edit: It also leaves us prime position with the likes of Illumina, Siemens, Thermo et al. Good to hear AN confirm in the Proactive event, that he also sees the longer term future as likely under one of the big players.

[broom23] 25/1/2024 15:06

FDA only care about products and certified test labs that are used in USA but they do monitor adverse reports from other competent authorities in other countries. Angle are on a winner here methinks.

[toffeeman] 25/1/2024 14:56

Re FDA and lab tests - won't affect labs outside US?

[broom23] 25/1/2024 14:53

Bones, the FDA have to conform to response guidelines set by USA government. It does not take them 'years' to do anything.

Recently moved in on Shield and Angle.

[bones698] 25/1/2024 14:52

Yup about. Sums it up spa

[rb1947] 25/1/2024 14:49

Plenty happening in the next 2 weeksUSA Conference next week and AJ bell investor meet on 6th of February

[dave4545] 25/1/2024 14:42

Just tried a 50k at 17.5p and it's NT looks like the mm's are short again and relying on the 1-2 sell 5-10 follow to bail the out but I feel any sellers this low might get locked out, just feel sentiment has turned today and any dip will be pounced on.

It's almost been "tipped" in a newsletter alongside other Bio's (spectactor)

[spa362] 25/1/2024 14:35

An ANGLE novice here - but feel like this is possible a good investment opportunity with limited downside. Angle seems to be one of the few companies that have got proven technology in this field which is scaleable and a secure cash position through to mid-2025. Lots of dialogue appears to be going on with partners. Is this a fair summary? I suppose my question is what would be a reasonable valuation of this company/ I would like to buy.